Trial · NCT07885202
Study of the Safety, Tolerability, Pharmacokinetics of VV147 Tablets in Chinese Healthy Participants.
NCT07885202, Phase 1, Not yet recruiting, Vigonvita Life Sciences
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study of the Safety, Tolerability, Pharmacokinetics of VV147 Tablets in Chinese Healthy Participants. Trials, record NCT07885202. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885202
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study of the Safety, Tolerability, Pharmacokinetics of VV147 Tablets in Chinese Healthy Participants.
- NCT number
- NCT07885202
- Status
- Not yet recruiting
- Phases
- Phase 1
- Enrollment
- 48 participants, estimated
- Lead sponsor
- Vigonvita Life Sciences
- Conditions
- Healthy Participants
- Interventions
- VV147 15mg Group, VV147 30mg Group, VV147 60mg Group, VV147 90mg Group, VV147 120mg Group, VV147 150mg Group
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cmax | 168 hours after administration | maximum observed plasma concentration |
| Primary | AUC0-t | 168 hours after administration | area under the plasma concentration time curve from time zero to the last measurable concentration |
| Primary | AUC0-∞ | 168 hours after administration | area under the plasma concentration-time curve from time zero to infinity |
| Primary | AUC0-24 | 24 hours after administration | Area under the plasma concentration time curve from time zero to 24 hours |
| Primary | Tmax | 168 hours after administration | time at which Cmax occurs |
| Primary | t1/2 | 168 hours after administration | half life of elimination |
| Primary | Ke | 168 hours after administration | elimination rate constant |
| Primary | CL/F | 168 hours after administration | apparent clearance |
| Primary | Vd/F | 168 hours after administration | apparent volume of distribution during the terminal phase |
| Primary | MRT | 168 hours after administration | mean residence time |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07885202
GET https://conductscience.org/api/trials/v1/NCT07885202/registered